FCMI
Foresite Capital Management III Portfolio holdings
AUM
$37.9M
This Quarter Return
+22.44%
1 Year Return
-6.87%
3 Year Return
+443.49%
5 Year Return
+535.97%
10 Year Return
–
AUM
$261M
AUM Growth
+$261M
(+13%)
Cap. Flow
-$22.7M
Cap. Flow
% of AUM
-8.71%
Top 10 Holdings %
Top 10 Hldgs %
85.17%
Holding
28
New
8
Increased
4
Reduced
9
Closed
3
Top Buys
| 1 |
BLCM
Bellicum Pharmaceuticals, Inc.
BLCM
|
$11.3M |
| 2 |
DERM
Dermira, Inc.
DERM
|
$6.01M |
| 3 |
MNTA
Momenta Pharmaceuticals, Inc.
MNTA
|
$5.75M |
| 4 |
LOXO
Loxo Oncology, Inc
LOXO
|
$4.21M |
| 5 |
Natera
NTRA
|
$2.53M |
Top Sells
| 1 |
AKAO
Achaogen, Inc.
AKAO
|
$34.4M |
| 2 |
Intellia Therapeutics
NTLA
|
$7.8M |
| 3 |
Editas Medicine
EDIT
|
$4.46M |
| 4 |
iRhythm Technologies
IRTC
|
$3.62M |
| 5 |
NSTG
NanoString Technologies, Inc.
NSTG
|
$2.38M |
Sector Composition
| 1 | Healthcare | 49.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AERI
1
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $72.4M | 27.79% | 1,596,701 -1,751 | -0.1% | -$79.4K |
|
|
ALDR
2
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
| $33.9M | 13.01% | 1,629,222 +894 | +0.1% | +$18.6K |
|
|
AKAO
3
DELISTED
Achaogen, Inc.
AKAO
| $31.4M | 12.06% | 1,245,187 -1,362,797 | -52% | -$34.4M |
|
|
AIMT
4
DELISTED
Aimmune Therapeutics, Inc.
AIMT
| $19.8M | 7.61% | 912,001 +8,111 | +0.9% | +$176K |
|
5
Wave Life Sciences
WVE
$1.53B
| $18.6M | 7.14% | 676,128 | – | – |
|
|
EPZM
6
DELISTED
Epizyme, Inc
EPZM
| $11.7M | 4.49% | 681,922 +76,683 | +13% | +$1.32M |
|
|
BLCM
7
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
| $11.3M | 4.35% | +918,000 | New | +$11.3M |
|
|
BPMC
8
DELISTED
Blueprint Medicines
BPMC
| $10.4M | 4% | 260,400 -39,600 | -13% | -$1.58M |
|
|
NSTG
9
DELISTED
NanoString Technologies, Inc.
NSTG
| $6.33M | 2.43% | 318,586 -119,547 | -27% | -$2.38M |
|
|
DERM
10
DELISTED
Dermira, Inc.
DERM
| $6.01M | 2.31% | +176,211 | New | +$6.01M |
|
|
MNTA
11
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $5.75M | 2.21% | +430,632 | New | +$5.75M |
|
12
Protagonist Therapeutics
PTGX
$3.67B
| $4.44M | 1.7% | 346,281 | – | – |
|
|
LOXO
13
DELISTED
Loxo Oncology, Inc
LOXO
| $4.21M | 1.62% | +100,000 | New | +$4.21M |
|
14
Aclaris Therapeutics
ACRS
$209M
| $4.18M | 1.6% | 140,000 -15,767 | -10% | -$470K |
|
15
Ascendis Pharma
ASND
$11.8B
| $2.8M | 1.07% | 100,000 -80,000 | -44% | -$2.24M |
|
|
16
iRhythm Technologies
IRTC
$5.46B
| $2.63M | 1.01% | 70,010 -96,200 | -58% | -$3.62M |
|
|
17
Natera
NTRA
$23.1B
| $2.53M | 0.97% | +285,731 | New | +$2.53M |
|
18
FibroGen
FGEN
$47.8M
| $2.17M | 0.83% | +87,984 | New | +$2.17M |
|
|
19
Intellia Therapeutics
NTLA
$1.22B
| $2.11M | 0.81% | 150,000 -553,563 | -79% | -$7.8M |
|
|
JNCE
20
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $2.01M | 0.77% | +91,600 | New | +$2.01M |
|
21
Larimar Therapeutics
LRMR
$310M
| $1.73M | 0.66% | 370,876 -98,528 | -21% | -$459K |
|
|
OREX
22
DELISTED
Orexigen Therapeutics, Inc.
OREX
| $1.31M | 0.5% | 380,530 +126,273 | +50% | +$434K |
|
|
BOLD
23
DELISTED
Audentes Therapeutics, Inc
BOLD
| $1.13M | 0.44% | 66,553 | – | – |
|
|
IMMU
24
DELISTED
Immunomedics Inc
IMMU
| $1.12M | 0.43% | +172,871 | New | +$1.12M |
|
|
XLRN
25
DELISTED
Acceleron Pharma Inc.
XLRN
| $526K | 0.2% | 19,886 | – | – |
|